Kidney Function Test Market

COVID-19 Complications Trigger Growth of Global Kidney Function Test

The Kidney Function Test Market is valued at USD 1093.6 Mn in 2026 and is projected to reach USD 1663.9 Mn,  growing at a CAGR of 6% by 2033.Global surge in renal disorders has propelled the demand for kidney function tests. The primary causative factors for rise in kidney disorders include chronic diseases including diabetes, cardiovascular disorders, hypertension, infections, renal calculi, cysts, and cancer. Certain specific and genetic diseases such as amyloidosis, alport’s syndrome, lupus nephritis, nephrotic syndrome, and renal tubular acidosis have also been responsible for the growth of Kidney Function tests market. In addition, the recent COVID-19 pandemic has led to significant risk of developing Acute Kidney Infection in people reported to have COVID infection. Thus, high risk patients with co-morbidities such as cardiovascular diseases and Type 2 Diabetes have been recommended to undergo Kidney Function tests as a part of COVID treatment guidelines thereby boosting the demand for Kidney Function Test.

The market by products includes dipsticks, reagents, and disposables. The dipstick market is expected to foresee the highest growth during the forecast owing to ease and convenience of these tests. These dipstick tests are extremely helpful for geriatric population as they do not need blood withdrawal thereby avoiding needle stick injuries consequently depicting a slow growth for blood kidney function tests.   

Growing awareness coupled with rise in significant investment made by the major players and favorable reimbursement policies including healthcare insurance coverage for such tests has enhanced the overall growth of kidney function tests. Recently in 2019, Renalytix AI plc announced CPT reimbursement code 105U for its KidneyIntelX test. Renalytix AI plc is a developer of clinical diagnostics tests for renal disorders using artificial intelligence. This company also intends to seek coverage from Medicare and private insurance payers for kidney diseases arising from type 2 diabetes.  Moreover, there has been huge grants flowing in support of chronic kidney diseases, organizations like Kidney International and International Society of Nephrology which have been collaboratively building, connecting, educating, training, and conducting research through obtaining of these grants. Thus, encouraging support from governments, companies and global professional associations are boosting the growth of kidney function test market.

Strategic Collaborations and Partnerships Driving Growth Of Kidney Function Tests Market

In September 2020, Baxter International collaborated with bioMerieux for CE approval of Nephroclear CC14 test. This test has been developed to predict persistent acute renal injury. The test is commercially expected to be launched in Western Europe in 2022.  In addition, partnerships for development of excellence care centers like Baxter International and Mayo Clinic in 2018, announced collaboration to establish renal care center in Florida. Such partnerships are further aiding in providing renal care services through availability of trained medical professional coupled with advanced renal therapeutic tests and equipment. In July 2019, Beckman Coulter and Gentian Diagnostics announced a six year agreement in expansion of business in field of renal testing. Gentian Diagnostics is a developer and manufacturer of reagents. As this company has a global reach, this collaboration will help Beckman Coulter deliver high quality renal tests to its customers globally.

Emerging Economies Have Accentuated Growth Opportunity for Kidney Function Test Market

Significant potential has been identified in emerging economies for kidney function test market including urine analysis. High prevalence of chronic diseases including diabetes and cardiovascular diseases, rise in disposable income, availability of improved healthcare infrastructure along with growing influx of patients as medical tourists in these countries like India, China, Brazil, Mexico, and Korea has boosted the kidney function test market. Major players are also exploring opportunities in these lucrative regions through significant investments and collaborations with local players. Thus, there has been a noteworthy uptake and installation of urine analyzers in these regions. Recently, In January 2021, Arkray Inc., released a compact automatic urine analyzer named AutionIdaten AE-4070, this instrument can offer screening tests for early detection of kidney diseases and diabetic nephropathy.

North America to Hold Lion’s Share in Global Kidney Function Test Market

North America accounted for the largest market for Kidney Function Tests Market, presence of leading players, awareness of kidney disease among the general population, supportive reimbursement policies and government initiatives are some factors helping the region to dominate the Kidney Function Tests Market. However, Asian region is anticipated to have fastest growth owing to favorable investments made by foreign market players.

The major players of this market include 

• Abbott
• Roche Diagnostics
• Siemens Healthineers
• Beckman Coulter (Danaher Corporation)
• Bio Rad Laboratories
• Sysmex Corporation
• Thermo Fisher Scientific
• BioMérieux
• Ortho Clinical Diagnostics
• Nihon Kohden Corporation
• Werfen
• Mindray Medical International
• Sysmex Partec
• DiaSorin
• Fujifilm Healthcare/Kodak Alaris

Global Kidney Function Test Market is Segmented as Below:

Kidney Function Test Market, by Product

• Dipsticks
• Reagents
• Disposables

Kidney Function Test Market, by Type

• Urine Tests
• Urine Protein Tests
• Creatinine Clearance Tests
• Micro albumin Tests
• Blood Tests
• Serum Creatinine Tests
• Glomerular Filtration Rate Tests
• Blood Urea Nitrogen Tests

Kidney Function Test Market, by End User

• Hospitals
• Diagnostics Laboratories
• Research Laboratories and Institutes

Kidney Function Test Market, by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa